SAN DIEGO, Nov. 28, 2012 /PRNewswire/ -- RainTree Oncology Services today announced it has added The Angeles Clinic and Research Institute in Los Angeles, Queens Medical Associates in New York City and Southern Cancer Center in Mobile, Ala. to its network of leading community oncology practices. The Company's expanding network includes community oncology practices seeking to optimize management of oral oncology medications as one means of achieving excellence in cancer care. In recent years, community oncology practices, which treat the majority of cancer patients in the United States, have been increasingly challenged by the rising prices of oral oncology medications.
"Many community oncologists find themselves in a healthcare quagmire, where leaving private practice often seems to be the simplest solution," said Dr. Jeffrey Patton, Raintree Oncology chief medical officer and co-founder. "This situation is unacceptable. Given that oncology drugs contribute enormously to the cost of care, we believe new information-driven techniques for acquistion and management of these drugs can yield important advances in efficiency and care."
RainTree Oncology's integrated Care Management platform provides pharmacy and technology solutions aligned with the initiatives of community oncology practices – large and small. The Company begins by leveraging its strong pharmaceutical relationships to help its members establish drug formularies based on effectiveness, safety and cost. RainTree Oncology Network members offering on-site prescription dispensing also benefit from collaborative consulting that aids in the development of care pathway strategies aligned with the practices' business and care objectives. Underlying the platform is proprietary technology, currently under development, that will arm practices with valuable information that can be used to improve practice performance.
"Queens Medical Associates is one of the largest private providers of oncology services by volume in the Northeast. Our patients are multicultural with complex and varied needs. The practice's dispensing pharmacy is growing dramatically in response to the growing number of oral cancer drugs. We are delighted to have joined RainTree Oncology Services which will help us increase our efficiency in the pursuit of the best patient care," said Dr. Barry Kaplan, president and practice founder.
Dr. Howard Levine, Pharmacy director said, "By joining other leading community oncology practices in the RainTree Oncology Network, we believe Queens Medical Associates will be able to provide an even higher level of professional services to our patients, helping them receive and maintain the best care while being treated with oral oncology medications."
About RainTree Oncology Services
RainTree Oncology Services provides leading-edge oral drug acquisition and management services that make a difference in the lives of cancer patients by: helping community oncology practices expand services and improve patient care, enhancing the economic model of community oncology practices and pioneering an integrated information network between physicians, payors and manufacturers to advance the state of the art in oral oncology. Since entering the oral group purchasing organization (GPO) market in August 2011, RainTree Oncology has signed contracts with leading pharmaceutical manufacturers enabling its members to enjoy benefits covering a substantial percentage of the oral oncology drug market. RainTree Oncology is physician centric, patient focused and community minded. For more information about RainTree Oncology Services visit www.raintreeoncology.com.
SOURCE RainTree Oncology Services